Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Baozun Q2 FY26 net income turns to RMB 17 million; revenue rises 7.5% to RMB 2.74 billion

Baozun Q2 FY26 net income turns to RMB 17 million; revenue rises 7.5% to RMB 2.74 billion

ReutersReuters2026/08/27 10:34
  • Baozun posted Q2 revenue of RMB 2.74 billion, up 7.5% year over year.
  • Operating income swung to RMB 63.4 million from an operating loss; margin improved to 2.3% from -0.4%.
  • Net income attributable to ordinary shareholders turned to RMB 17 million; earnings per ADS swung to RMB 0.29.
  • E-Commerce revenue rose to RMB 2.3 billion, while Brand Management climbed to RMB 485.6 million, up 21.9%.
  • Management cited stronger BEC efficiency, continued Gap momentum, early AI automation pilots; 2028 non-GAAP operating income target raised to at least RMB 700 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Baozun Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608270631PR_NEWS_USPR_____CN34948) on August 27, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas